Institutional Ownership Viridian Therapeutics, Inc.\De (VRDN)
This table provides information about the institutional ownership of Viridian Therapeutics, Inc.\De (VRDN). We have compiled data on the 202 institutions that hold shares in the stock, with a total of 79.2 Million shares, which have been reported (via 13F filing form) to have a value of $1.06 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
J.Safra Asset Management Corp
|
Apr 25, 2025 Q1 2025 |
30
shares
|
$406
0.0% of portfolio
|
Q1 2025
Added 42.86%
|
|
Stephens Consulting, LLC
Flint, MI |
Apr 17, 2025 Q1 2025 |
25
shares
|
$338
0.0% of portfolio
|
Q1 2025
New holding
|
|
Td Private Client Wealth LLC
New York, NY |
Apr 29, 2025 Q1 2025 |
18
shares
|
$243
0.0% of portfolio
|
Q1 2025
New holding
|
|
Institutional & Family Asset Management, LLC
|
Jul 05, 2024 Q2 2024 |
18
shares
|
$243
0.0% of portfolio
|
Q3 2023
Added 80.0%
|
|
Creative Financial Designs Inc
|
Apr 23, 2025 Q1 2025 |
10
shares
|
$135
0.0% of portfolio
|
Q1 2025
New holding
|
|
Principal Securities, Inc.
Des Moines, IA |
Apr 30, 2025 Q1 2025 |
9
shares
|
$121
0.0% of portfolio
|
Q4 2024
New holding
|
|
Ever Source Wealth Advisors, LLC
|
Feb 07, 2025 Q4 2024 |
6
shares
|
$81
0.0% of portfolio
|
Q4 2024
New holding
|
|
Wealth Trak Capital Management LLC
Virginia Beach, VA |
Feb 12, 2025 Q4 2024 |
5
shares
|
$67
0.0% of portfolio
|
Q4 2024
New holding
|
|
Covestor LTD
Boston, MA |
Feb 13, 2025 Q4 2024 |
5
shares
|
$67
0.0% of portfolio
|
Q4 2024
Reduced 28.57%
|
|
Farther Finance Advisors, LLC
San Francisco, CA |
Apr 14, 2025 Q1 2025 |
1
shares
|
$13
0.0% of portfolio
|
Q4 2023
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|
|
Nomura Asset Management CO LTD
Tokyo, M0 |
Feb 12, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|
|
Ifp Advisors, Inc
|
Feb 04, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|